DDR1 and endometrial cancer: The above study found that the alterations in DDR proteins in solid tumors, including endometrial cancer, are closely related to patient survival, which can serve as a marker to predict patients’ prognosis and may guide the targeted therapy with corresponding small-molecule inhibitors.